Loading insider details...
Beta
Latest Form 4 (May 26, 2026): Grant/Award of 45,871 BHC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 26, 2026 | Bausch Health Companies Inc. (BHC) | Grant/Award | 45,871 | n/a |
| Apr 27, 2026 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to Issuer | 76,275 | $1.11M |
| Jun 6, 2025 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 20,414 | n/a |
| Feb 14, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,113 | n/a |
| Feb 12, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,860 | n/a |
| Feb 4, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 2,769 | n/a |
| Dec 19, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 5,487 | n/a |
| Nov 12, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 5,140 | $399.9K |
| Jun 7, 2024 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/Award | 11,847 | n/a |
| Feb 15, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 1,114 | $148.1K |